Difference between revisions of "Boots Healthcare International"
| Line 1: | Line 1: | ||
| − | + | In October 2005 [[Boots]] agreed to sell its over-the-counter medicines business, Boots Healthcare International, which markets brands such as [[Clearasil]], [[Nurofen]], [[Optrex]], [[E45]] and [[Strepsils]], to the Anglo-Dutch household products company [[Reckitt Benckiser]] for £1.936 billion. The disposal was completed on 31 January 2006. | |
Revision as of 00:07, 1 December 2007
In October 2005 Boots agreed to sell its over-the-counter medicines business, Boots Healthcare International, which markets brands such as Clearasil, Nurofen, Optrex, E45 and Strepsils, to the Anglo-Dutch household products company Reckitt Benckiser for £1.936 billion. The disposal was completed on 31 January 2006.
